Chlorthalidone 25mg

DRUG3 trials

Sponsors

HanAll BioPharma Co., Ltd., Yuhan Corporation, Insel Gruppe AG, University Hospital Bern

Conditions

HypertensionKidney Stone

Phase 1

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

CompletedNCT01806363

HanAll BioPharma Co., Ltd.Hypertension

Start: 2012-11-30End: 2013-06-30Target: 60Updated: 2014-02-25

PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

CompletedNCT02496910

Yuhan CorporationHypertension

Start: 2015-06-30End: 2015-09-30Target: 180Updated: 2015-09-25

Phase 2

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

RecruitingNCT06111885

Insel Gruppe AG, University Hospital BernKidney Stone

Start: 2024-10-01End: 2027-06-30Target: 99Updated: 2025-02-19

Related Papers

Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR)

BMJ Open2025-06-012 citations

Evaluation of a Pharmacokinetic Interaction between Telmisartan and Chlorthalidone in Healthy Male Adult Subjects.

2016-08-011 citations